C. Hale, Obstructive sleep apnea and cardiovascular disease and mortality: the argument for causality, J Insur Med, vol.37, issue.4, pp.272-8208, 2005.

J. Lesske, E. Fletcher, G. Bao, and T. Unger, Hypertension caused by chronic intermittent hypoxia--influence of chemoreceptors and sympathetic nervous system, J Hypertens, vol.15, pp.1593-60306, 1997.

M. Pratt-ubunama, M. Nishizaka, R. Boedefeld, S. Cofield, S. Harding et al., Plasma Aldosterone Is Related to Severity of Obstructive Sleep Apnea in Subjects With Resistant Hypertension, Chest, vol.131, issue.2, pp.453-914, 2007.
DOI : 10.1378/chest.06-1442

N. Kanagy, B. Walker, and L. Nelin, Role of Endothelin in Intermittent Hypoxia-Induced Hypertension, Hypertension, vol.37, issue.2, pp.511-507, 2001.
DOI : 10.1161/01.HYP.37.2.511

F. Stanke-labesque, J. Pepin, T. De-jouvencel, C. Arnaud, J. Baguet et al., Leukotriene B4 pathway activation and atherosclerosis in obstructive sleep apnea, The Journal of Lipid Research, vol.53, issue.9, pp.1944-51, 2012.
DOI : 10.1194/jlr.P022814

P. Dandona, S. Dhindsa, H. Ghanim, and A. Chaudhuri, Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade, Journal of Human Hypertension, vol.15, issue.1, pp.20-27, 2006.
DOI : 10.1161/01.RES.0000130944.49657.b8

S. Benson, H. Pershadsingh, C. Ho, A. Chittiboyina, P. Desai et al., Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPAR??-Modulating Activity, Hypertension, vol.43, issue.5, pp.993-1002, 2004.
DOI : 10.1161/01.HYP.0000123072.34629.57

V. Peppard, P. Gottlieb, and D. , independently of AT1 receptor or PPARgamma, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes Epidemiology of obstructive sleep apnea: a population health perspective, Am J Physiol Endocrinol Metab. Am J Respir Crit Care Med, vol.302165, issue.39, pp.286-961217, 2002.

E. Larkin, C. Rosen, H. Kirchner, A. Storfer-isser, J. Emancipator et al., Variation of C-reactive protein levels in adolescents: association with sleepdisordered breathing and sleep duration Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force, Circulation. Epub Sleep, vol.121112022, issue.135, pp.1978-84667, 1999.

G. Maislin, R. Schwab, B. Staley, B. Benediktsdottir, and I. Olafsson, Canadian Thoracic Society guidelines: diagnosis and treatment of sleep disordered breathing in adults The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort, Can Respir J. Sleep, vol.131035, issue.16, pp.387-92921, 2006.

N. Punjabi, B. Caffo, J. Goodwin, D. Gottlieb, A. Newman et al., Sleep-Disordered Breathing and Mortality: A Prospective Cohort Study, PLoS Medicine, vol.25, issue.8, p.1000132, 2009.
DOI : 10.1371/journal.pmed.1000132.t005

K. Monahan, A. Storfer-isser, R. Mehra, E. Shahar, M. Mittleman et al., Triggering of nocturnal arrhythmias by sleep-disordered breathing events Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study, J Am Coll Cardiol. Epub Circulation, vol.5410122, pp.1797-804, 2009.

P. Peppard, T. Young, M. Palta, J. Skatrud, Q. Lin et al., Prospective study of the association between sleep-disordered breathing and hypertension Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults, N Engl J Med. Epub Sleep Breath, vol.1434216, issue.20206, pp.1378-84571, 1921.

S. Pamidi, R. Aronsohn, E. Tasali, A. Adedayo, O. Olafiranye et al., Obstructive sleep apnea: role in the risk and severity of diabetes Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism Is obstructive sleep apnea an independent risk factor for stroke? A critically appraised topic, Best Pract Res Clin Endocrinol Metab. Neurologist, vol.243016, issue.224, pp.703-15269, 2010.

P. Theroux, L. P. Bortolotto, L. Lorenzi, M. Figueiredo, A. Krieger et al., Progression of atheroma: a struggle between death and procreation, Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. Pathophysiology of coronary artery disease. Circulation. Epub Arterioscler Thromb Vasc Biol, vol.1511122, issue.9259, pp.1512-313481, 1995.

G. F. Filho, L. Boulet, P. Poirier, J. Tardif, and J. Rodes-cabeau, Early signs of atherosclerosis in obstructive sleep apnea Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study, Am J Respir Crit Care Med. Int J Cardiol, vol.17213229, issue.29, pp.613-8203, 2005.

C. Arnaud, M. Dematteis, J. Pepin, J. Baguet, P. Levy et al., The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors Intermittent hypoxia activated cyclooxygenase pathway: role in atherosclerosis Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?, Epub 2005/11/24. 31. Drager LF,. Capra V, Back M, Barbieri SS, Camera M, Tremoli E, Rovati GE. Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke, pp.113-253407, 2003.

M. Sultan, A. Ovchinnikova, O. Hansson, and G. , 5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation, Arterioscler Thromb Vasc Biol. Circ Res. Epub, vol.22100, issue.37, pp.443-9946, 2002.

Y. Zhou, J. Wang, L. Li, H. Yang, L. Wen-de et al., Expanding expression of the 5-lipoxygenase/leukotriene B4 pathway in atherosclerotic lesions of diabetic patients promotes plaque instability Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease Effects of dietary weight loss on obstructive sleep apnea: a meta-analysis. Sleep Breath Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea, Arterioscler Thromb Vasc Biol. Biochem Biophys Res Commun. Proc Natl Acad Sci U S A. Epub J Allergy Clin Immunol. Am J Respir Crit Care Med, vol.25363102129179, issue.4048113411, pp.1665-7030, 2005.

S. Montesi, B. Edwards, A. Malhotra, J. Bakker, L. Bazzano et al., Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study CPAP treatment in the coexistence of obstructive sleep apnea syndrome and metabolic syndrome, results of one year follow up A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II International union of pharmacology. XXIII. The angiotensin II receptors, 52. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease, pp.587-96417, 2000.

M. Mogi, M. Iwai, M. Horiuchi, R. Alexander, M. Akers et al., Emerging Concepts of Regulation of Angiotensin II Receptors: New Players and Targets for Traditional Receptors, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.27, issue.12, pp.2532-2541, 2007.
DOI : 10.1161/ATVBAHA.107.144154

C. Brilla, H. Rupp, R. Funck, B. Maisch, H. Weber et al., The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure Epub 1995/12/01. 57 Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition Functions and mechanisms of redox regulation of cysteine-based phosphatases, Mol Pharmacol. Eur Heart J. J Clin Invest. Cardiovasc Res. Antioxid Redox Signal, vol.5512169347714, issue.60, pp.142-9107, 1994.

P. Mehta, K. Griendling, S. Kurz, T. Munzel, M. Tarpey et al., VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone, J Clin Invest. Am J Physiol Cell Physiol. J Clin Invest, vol.921029297, issue.1418, pp.1866-74, 1993.

A. Kallianos, K. Kostopoulos, C. Seretis, E. Koufogiorga, and A. Protogerou, factor-kappaB activation induced by intracellular oxidative stress Dzau VJ Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis Effect of CPAP treatment on endothelial function and plasma CRP levels in patients with sleep apnea, Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear, pp.645-511047, 2000.

H. Yanagisawa, J. Morrissey, A. Morrison, M. Purkerson, S. Klahr et al., Role of ANG II in eicosanoid production by isolated glomeruli from rats with bilateral ureteral obstruction Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea, Am J Physiol. Am J Respir Crit Care Med, vol.12258182, issue.687, pp.85-93954, 1990.

F. Stanke-labesque, M. Back, B. Lefebvre, R. Tamisier, J. Baguet et al., Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia Epub 2009/07/15. 71. Hills M, Armittage P. The two-period cross-over clinical trial BMI classification. World Health Organization Resistin levels in patients with obstructive sleep apnoea syndrome--the link to subclinical inflammation? Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI, J Allergy Clin Immunol. Br J Clin Pharmacol Med Sci Monit. Epub Chest, vol.1241026141, issue.743, pp.364-70, 1979.